Uploaded February 2026 | Updated September 2026, 2 weeks ago
Dr. Beth Weise is the Research and Overdose Prevention Coordinator for The Sidewalk Project, a non-profit organization that aids unhoused, drug-using, survivor & sex worker populations by providing direct services including crisis response, system advocacy, wound care, job placement, medication-assisted treatment (MAT), and creative community resources for mental health. Her work aims to influence future drug policy with novel evidence-based research that also advocates and empowers people who use drugs to feel safe and prevent fatal overdose
At CannMed 26, Beth will present "Cannabidiol to Mitigate Opioid Induced Respiratory Depression". During our conversation, we discuss:
- What causes Opioid Induced Respiratory Depression and how cannabinoids play a role
- How CBD can be used in combination with Naloxone to reduce withdrawal-related side effects
- How Beth’s research can be applied in real-world scenarios
Thanks to This Episode’s Sponsor: Humanity Heroes
Humanity Heroes provides compassionate support to the unhoused community by delivering essential supplies and resources directly to those in need. Humanity Heroes partners with other nonprofits by empowering them to extend their reach and impact within their own communities. Together, they strive to create a world where every person has access to the resources and support they need to thrive.
Learn more at JoinHumanityHeroes.org
Additional Resources:
- THRRIV.org
- [Webinar] Bridging the Gap: Tech-Supported Peer Connections to Reduce - - Overdose Fatalities - youtube.com/watch?v=tralDTJlhqs
Register for CannMed 26 - cannmedevents.com
Dr. Beth Weise is the Research and Overdose Prevention Coordinator for The Sidewalk Project, a non-profit organization that aids unhoused, drug-using, survivor & sex worker populations by providing direct services including crisis response, system advocacy, wound care, job placement, medication-assisted treatment (MAT), and creative community resources for mental health. Her work aims to influence future drug policy with novel evidence-based research that also advocates and empowers people who use drugs to feel safe and prevent fatal overdose
At CannMed 26, Beth will present "Cannabidiol to Mitigate Opioid Induced Respiratory Depression". During our conversation, we discuss:
- What causes Opioid Induced Respiratory Depression and how cannabinoids play a role
- How CBD can be used in combination with Naloxone to reduce withdrawal-related side effects
- How Beth’s research can be applied in real-world scenarios
Thanks to This Episode’s Sponsor: Humanity Heroes
Humanity Heroes provides compassionate support to the unhoused community by delivering essential supplies and resources directly to those in need. Humanity Heroes partners with other nonprofits by empowering them to extend their reach and impact within their own communities. Together, they strive to create a world where every person has access to the resources and support they need to thrive.
Learn more at JoinHumanityHeroes.org
Additional Resources:
- THRRIV.org
- [Webinar] Bridging the Gap: Tech-Supported Peer Connections to Reduce - - Overdose Fatalities - youtube.com/watch?v=tralDTJlhqs
Register for CannMed 26 - cannmedevents.com










![What were some peaks/trends in the data that seemed informative in your CHS survey? - Codi Peterson
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ What were some peaks/trends in the data that seemed informative in your CHS survey? - Codi Peterson](https://i.ytimg.com/vi/lFtfCNKV8rE/mqdefault.jpg)